Search for a trial

A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR 042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

This study has been transitioned to CTIS with ID 2024-510605-28-00 check the CTIS register for the current data. Primary Objective• To compare the progression free survival (PFS) of programmed death-ligand 1 (PD-L1) positive patients with Stage III…

Ovarian cancer treatment with a liposome formulated mRNA Vaccine in combination with (neo-)adjuvant chemotherapy

Systemic induction / expansion of vaccine antigen-specific T cells.

Ovarian cancer treatment with a liposome formulated mRNA Vaccine in combination with neo-adjuvant chemotherapy

To induce a vaccine specific immune response, hereby we hope to introduce the possibility of a new treatment to improve patient outcome and survival.